Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Treasury Shares (2020 - 2025)

Beauty Health (SKIN) has disclosed Treasury Shares for 6 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 70.3% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 70.3% year-over-year, with the annual reading at $2.2 million for FY2025, 70.3% down from the prior year.
  • Treasury Shares for Q4 2025 was $2.2 million at Beauty Health, down from $10.7 million in the prior quarter.
  • The five-year high for Treasury Shares was $15.8 million in Q1 2025, with the low at $210000.0 in Q2 2021.
  • Average Treasury Shares over 5 years is $3.7 million, with a median of $2.3 million recorded in 2022.
  • The sharpest move saw Treasury Shares soared 973.35% in 2022, then plummeted 70.3% in 2025.
  • Over 5 years, Treasury Shares stood at $380775.0 in 2021, then surged by 556.59% to $2.5 million in 2022, then plummeted by 47.74% to $1.3 million in 2023, then surged by 455.23% to $7.3 million in 2024, then plummeted by 70.3% to $2.2 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.2 million, $10.7 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.